Guest guest Posted February 1, 2011 Report Share Posted February 1, 2011 “How long have I had this cancer, Doctor?” This is a question that patients frequently ask their oncologist. In many instances, the answer to the question is not particularly relevant since treatment approaches may not be influenced by the “age” of the cancer. However, in some instances the age of a cancer, which implies its natural history, may influence treatment recommendations. Some understanding of their cancer’s age may help to alleviate patients’ concerns regarding any delays in treatment (ie, they will be less concerned about a modest delay if they understand that the tumor has been present for a long time). " http://tinyurl.com/4fzysx6 **************************** STEM CELLS: The cancer stem cell (CSC) theory was first proposed to explain the fact that only a small proportion of leukemia or solid tumor cells have the capacity to induce growing tumors in immunodeficient mice. This tumorigenic subpopulation was found to possess stem cell markers, and to form spheroids in culture. In 1997, Bonnet and Dick isolated a subpopulation of MYELOID LEUKEMIA CELLLS that express a specific surface marker—CD34—but lack the CD38 marker. These cells were able to initiate leukemia in non-obese diabetic, severe combined immunodeficient (NOD/SCID) mice. In 2003, Al-Hajj and his colleagues demonstrated that only a small subpopulation of CD44+/CD24low cells isolated from human breast cancer tissue were able to develop a tumor in immunodeficient mice. " Normal stem cells travel in the circulation, extravasate, intravasate, invade, and colonize normal tissue during regeneration and healing. In addition, normal stem cells induce angiogenesis in healing tissues.[8,18,19] These same physiologic invasion programs are employed by CSCs. Thus, CSCs are thought to be enriched during invasion and metastasis. " Read more.......... http://tinyurl.com/4ol3974 ********************** DEMAND FOR CANCER DRUGS WILL INCREASE: " This year, an estimated 1.6 million new cases of cancer will be diagnosed in the United States. By 2030, this number is expected to increase by 45%, to 2.3 million new cases. Notably, older adults and minorities will have the highest rates of increase; specifically, 70% of all cancers will be diagnosed in people aged 65 years or older, while 28% of all cancers will be diagnosed in minorities. As Bunnell and Shulman note, resource utilization is the highest in the 12 months following an initial diagnosis of cancer. Due to changing demographic trends, the demands for oncology services will dramatically increase in the next 20 years, burdening an already fragmented US health care system. In addition to the projected growth of the U.S. population, improvements in cancer screening and advances in treatment have resulted in larger numbers of cancer patients and cancer survivors. Both groups will require ongoing medical care from a multidisciplinary team of physicians and other healthcare providers. The overall costs to treat cancer may explode as the cost of treating an individual cancer patient continues to increase and the number of cancer patients continues to grow. " http://tinyurl.com/4tvc96d fyi, Lottie Duthu Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.